Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6260
Rank
โ‚น55.27 B
Marketcap
โ‚น2,764
Share price
0.33%
Change (1 day)
N/A
Change (1 year)

Earnings for Avalon Pharma (Middle East Pharmaceutical) (4016.SR)

Earnings in 2024 (TTM): โ‚น1.00 Billion

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current earnings are N/A. In the company made an earning of N/A. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Avalon Pharma (Middle East Pharmaceutical) from to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น1.00 B